ABVE-PC and modified BEACOPP regimen in Indian children with Hodgkin lymphoma: Feasibility and efficacy

AIMS: To study the toxicity of ABVE-PC (doxorubicin, bleomycin, vincristine, etoposide, prednisone and cyclophosphamide) and modified-BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) in intermediate-risk and high-risk Hodgkin lymphoma patients. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayabose, Somasundaram, Viswanathan, Kasi, Kumar, Vignesh, Annamalai, Annapoorani, Srinivasan, Arathi, Scott, Julius Xavier, Rathnam, Krishnakumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854041/
https://www.ncbi.nlm.nih.gov/pubmed/27168709
http://dx.doi.org/10.4103/0971-5851.180142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854041/
https://www.ncbi.nlm.nih.gov/pubmed/27168709
http://dx.doi.org/10.4103/0971-5851.180142

Ejemplares similares